Similar to metastatic melanoma patients (Supplementary Fig. 1a), mice bearing multiple primary tumors mounted a mixed response to anti-PD-1 treatment (Fig. 1b; Supplementary Fig. 1b, c). The gene discussed is PDCD1; the disease is metastatic melanoma.